Mr
Neil
McKechnie

Consultant

Glasgow Office Edinburgh Office

Engineering

Telephone. +44(0) 141 229 5800
Email. [email protected]

Experience

Neil has a background in Engineering having chanced upon the IP profession after completing an Engineering degree at the University of Strathclyde. He initially completed his training with a well-known Glasgow based firm. That was more than 35 years ago and Neil has gathered a wealth of experience in the IP field in that time. He has advised clients from private individuals, new start businesses and SMEs through to multi national organisations across a range of industries and the broad spectrum of their IP needs.

Being a dual qualified Patent and Trade Mark Attorney lets Neil see the big picture for his clients and he provides pragmatic, sensible advice in a plain speaking style. Having himself helped set up, run and subsequently sold a successful private practice IP firm, Neil is well qualified to understand the challenges facing entrepreneurs and businesses today and how IP fits within that.

Having exited his previous business following its sale to a major competitor Neil joined HGF in 2008 shortly after the opening of HGF’s first Scottish office in Glasgow. Since then he has played a significant role in seeing HGF’s Scottish presence grow from small beginnings in a one room Glasgow office to having a major presence in Glasgow, Aberdeen and Edinburgh with an expanding team now comprising more than 20 attorneys and a growing support team. Neil looks forward to assisting your business make the most of their IP assets.

Qualifications

Patent Attorney

Chartered (UK)
European

Trade Mark Attorney

Chartered (UK)
European


BSC

Electrical & Electronic Engineering

Recognition

World Trade Mark Review

Consultant Neil McKechnie is “both personable and a great communicator”. “He is able to explain issues in a straightforward way, and provides level-headed, pragmatic advice at a transparent fee.”

View recognition online

Publications

World Trademark Review 1000 2022

View publication online

WTR 1000 2021

View publication online

WTR 1000 2020

View publication online

WTR 1000 2019

View publication online

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

3D shape trade marks for medical devices

Innovation in medical devices continues strongly and the introduction of IoT and 3D printing (amongst others) has led to an acceleration in new medical devices. Whilst patents and designs are …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

“For medical purposes” – a case for unblurring the lines between pharma and nutritional products

Food-pharma industry convergence is not a new development. In 2013, a study of the patent citation data of 274 published European patents by 5 EU Medical Nutrition companies revealed the …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article
Event - 30th April 2022

INTA 2022 Annual Meeting Live+

The HGF European team will be attending the INTA 2022 Annual Meeting Live+. It is being held on 30th April – 4th May in Washington, D.C. INTA brings together the …

Event details

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.